Breaking News
Take Action For The International Thalassaemia Day 2021
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System
LIVING WITH THALASSAEMIA: A STRUGGLE & MANAGEMENT by Pranab Mishra
The International Thalassaemia Day 2021 Official Page is Now Live!
TIF Presents Its Newly Launched SCD Educational Course for Healthcare Professionals On 9 April
Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?
COMING UP: New TIF Webinar On ”COVID-19 Vaccinations & Patients With Haemoglobin Disorders”
A Head-to-Head Comparison of BMT, Gene Therapy & Gene Editing Through A Brand New TIF Infographic
Potentially Curative Approaches for β-Thalassaemia (2021)
The International Thalassaemia Day 2021 Theme Has Been Announced
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Search for
RSS
Instagram
YouTube
Twitter
Facebook
Home
/
European Medicines Agency
European Medicines Agency
TIF’s Point of View: Medicines Regulatory Systems – Continued Strengthening Is Required
NOVITÀ
Febbraio 9, 2021
TIF’s Point of View: Medicines Regulatory Systems – Continued Strengthening Is Required
Access to quality-assured medical products improves health and saves lives. Nevertheless, one third of the world’s population lacks timely access to quality-assured medicines while estimates indicate that at least 10%…
Back to top button
Close
Search for
Cookies
This site uses cookies.
Find out more
Okay, thanks
